Clinical Trial Update: The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update announcing an early Phase 1 study of UTAA91 injection for refractory rheumatoid arthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• UTAA91

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Rheumatoid Arthritis (RA) | EARLY_Phase 1 | Status: RECRUITING